Addition of octreotide functional imaging to cross-sectional computed tomography or magnetic resonance imaging for the detection of neuroendocrine tumors: added value or an anachronism? uri icon

Overview

publication date

  • November 15, 2010

Research

keywords

  • Magnetic Resonance Imaging
  • Neuroendocrine Tumors
  • Octreotide
  • Radiopharmaceuticals
  • Tomography, Emission-Computed, Single-Photon
  • Tomography, X-Ray Computed

Identity

Scopus Document Identifier

  • 79951997242

Digital Object Identifier (DOI)

  • 10.1200/JCO.2010.32.8559

PubMed ID

  • 21079131

Additional Document Info

volume

  • 29

issue

  • 3